{"disease":{"id":"acquired-immunodeficiency-syndrome","name":"acquired immunodeficiency syndrome"},"drugs":{"marketed":[{"drug_id":"sulfadiazine","indication_name":"Toxoplasmosis associated with acquired immunodeficiency syndrome","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sulfadiazine","generic_name":"SULFADIAZINE","company_name":"Eli Lilly","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2A","drug_class":"Sulfonamide Antibacterial [EPC]","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT00434070","title":"Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring","phase":"","overall_status":"COMPLETED","enrollment_count":1012,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05031819","title":"Managing Hypertension Among People Living With HIV","phase":"NA","overall_status":"COMPLETED","enrollment_count":960,"lead_sponsor_name":"Dr. Dike Ojji","has_results":false},{"nct_id":"NCT04772469","title":"Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men","phase":"NA","overall_status":"COMPLETED","enrollment_count":934,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT01705574","title":"Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":583,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT04122404","title":"POC Strategies to Improve TB Care in Advanced HIV Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":425,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT00474370","title":"Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":400,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT01497899","title":"Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":279,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT01448707","title":"A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":274,"lead_sponsor_name":"Janssen-Cilag International NV","has_results":true},{"nct_id":"NCT05685641","title":"Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City","phase":"NA","overall_status":"UNKNOWN","enrollment_count":211,"lead_sponsor_name":"National Institute of Respiratory Diseases, Mexico","has_results":false},{"nct_id":"NCT03583138","title":"HIV, Buprenorphine, and the Criminal Justice System (STRIDE2)","phase":"","overall_status":"COMPLETED","enrollment_count":159,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT01968551","title":"Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03777371","title":"Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation","phase":"","overall_status":"COMPLETED","enrollment_count":128,"lead_sponsor_name":"Kanuni Sultan Suleyman Training and Research Hospital","has_results":false},{"nct_id":"NCT03182738","title":"Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Columbia University","has_results":true},{"nct_id":"NCT02479698","title":"Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT00001650","title":"Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT01967940","title":"Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT01721109","title":"Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03746600","title":"Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Carolyn Lauckner","has_results":true},{"nct_id":"NCT01550341","title":"HIV, Buprenorphine, and the Criminal Justice System","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Yale University","has_results":true},{"nct_id":"NCT01590017","title":"Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"AIDS Malignancy Consortium","has_results":true},{"nct_id":"NCT04983030","title":"Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults","phase":"PHASE1, PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Boris Juelg, MD PhD","has_results":false},{"nct_id":"NCT00394004","title":"Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials","phase":"","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT01976715","title":"Study of People With HIV Infection Who Have High Viral Loads Despite Combination Antiretroviral Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":26,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT00001560","title":"Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers","phase":"","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04192487","title":"Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Napo Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT03513328","title":"Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT00243568","title":"Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false}],"total":27},"guidelines":[],"source":"Drug Landscape verified database"}